Biochemical tests for the diagnosis of high risk of preterm birth

1. Фаткуллин И.Ф., Ахметгалиев А.Р., Мунавирова А.А., Фаткуллин Ф.И. Преимущества применения диагностической экспресс-тест-системы для определения плацентарного α-микроглобулина-1 в цервикальном содержимом для идентификации начавшихся/угрожающих преждевременных родов. Акушерство и гинекология. 2018; 1: 62-8. https://dx.doi.org/10.18565/aig.2018.1.62-68 [Fatkullin I.F., Akhmetgaliev A.R., Munavirova A.A., Fatkullin F.I. Advantages of using a rapid diagnostic test system to determine placental α1-microglobulin in the cervical contents for identification of incipient/threatened preterm labor. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (1): 62-8. (in Russian) https://dx.doi.org/10.18565/aig.2018.1.62-68]

2. Mella M.T., Berghella V. Prediction of preterm birth: cervical sonography. Rev. Semin. Perinatol. 2009; 33(5): 317-24.

3. Berghella V., Hayes E., Visintine J., Baxter J.K. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst. Rev. 2008; (4): CD006843. Available at: http://cochranelibrary-wiley.com/

4. Conde-Agudelo A., Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancy: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 2010; 23(12): 1365-76.

5. Berghella V., Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol. 2016; 215(4): 431-8.

6. Ruma M.S., Bittner K.C., Soh C.B. Current perspectives on the use of fetal fibronectin testing in preterm labor diagnosis and management. Am. J. Manag. Care. 2017; 23(Suppl.19): S356-62.

7. Khambay H., Bolt L.A., Chandiramani M., De Greeff A., Filmer J.E., Shennan A.H. The Actim Partus test to predict pre-term birth in asymptomatic high-risk women. J. Obstet. Gynaecol. 2012; 32(2): 132-4.

8. Fuchs F., Houllier M., Leparco., Guyot A., Senat M.V., Fernandez H. Performance of cervical phIGFBP-1 test alone or combined with short cervical length to predict spontaneous preterm birth in symptomatic women. Sci. Rep. 2017; 7(1): 10856.

9. Di Renzo G.C., Cabero Roura L., Facchinetti F., Helmer H., Hubinont C., Jacobsson B. et al. Preterm labor and birth management: Recommendations from the European Association of Perinatal Medicine. J. Matern. Fetal Neonatal Med. 2017; 30(17): 2011-30. Available at: https://www.tandfonline.com/

10. Bolotskikh V., Borisova V. Combined value of placental alpha microglobulin-1 detection and cervical length via transvaginal ultrasound in the diagnosis of preterm labor in symptomatic patients. J. Obstet. Gynaecol. Res. 2017; 43(8): 1263-9.

11. Lotfi G., Faraz S., Nasir R., Somini S., Abdeldayem R.M., Koratkar R. et al. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions. J. Matern. Fetal Neonatal Med. 2017; October 26: 1-5.

12. Melchor J.C., Navas H., Marcos M., Iza A., de Diego M., Rando D. et al. Retrospective cohort study of PAMG-1 and fetal fibronectin test performance in assessing spontaneous preterm birth risk in symptomatic women attending an emergency obstetrical unit. Ultrasound Obstet. Gynecol. 2017; Aug 29. Available at: https://www.ncbi.nlm.nih.gov/

13. Hadzi-Lega M., Maier J.T., Helmer H., Hellmeyer L., Markova A.D., Poposka A. Comparison of PAMG-1 and phIGFBP-1 tests for the prediction of preterm delivery in patients with preterm labor. Open J. Obstet. Gynecol. 2017; 7(3): 358-68.

14. Ravi M., Beljorie M., El Masry K. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor. J. Matern. Fetal Neonatal Med. 2018; May 28: 1-6.

15. Melchor J.C., Khalil A., Wing D., Schleussner E., Surbek D. Prediction of preterm delivery in symptomatic women using placental alpha-microglobulin-1, fetal fibronectin and phosphorylated insulin-like growth factor-binding protein-1 tests: systematic review and meta-analysis stratified by risk. Ultrasound Obstet. Gynecol. 2018; Jun 19. DOI: 10.1002/uog.19119. [Epub ahead of print]. Available at: https://www.ncbi.nlm.nih.gov/

16. Di Fabrizio L., Giardina I., Cetin I., Di Tommaso M., Ciavattini A., Locci M. et al. New methods for prediction of preterm birth: the PAMG-1 test. Minerva Ginecol. 2018; May 31. DOI: 10.23736/S0026-4784.18.04243-0. [Epub ahead of print]. Available at: https://www.ncbi.nlm.nih.gov/

17. Van Holsbeke C., Dam K., Staelens A., Mesens T., Corremans A. Comparison of the fetal fibronectin (Rapid fFN) and placental alpha microglobulin-1 (PartoSure) tests for predicting imminent spontaneous preterm birth. Ultrasound Obstet. Gynecol. 2016; 48(1): 84.

18. Петрунин Д.Д., Грязнова И.М., Петрунина Ю.А., Татаринов Ю.С. Сравнение иммунохимических и физико-химических характеристик хорионических α1- и α2-микроглобулинов плаценты человека. Бюлл. эксперим. биологии и медицины. 1978; 85(5): 658-61. [Petrunin D.D., Gryaznova I.M., Petrunina Y.A., Tatarinov Yu.S. Comparative immunochemical and physicochemical characteristics of chronicα1 and α2 -microglobulins of the human placenta. Bull. Exp. Biol. Med. 1978; 85(5): 658-61. (in Russian)]

19. Fuchs B.B., Boltovskaya M.N., Zaraiskii E.I., Nazimova S.V. Monoclonal antibodies against placental alpha-1-microglobulin (PAMG-1) Int. J. Immunopharmacol. 1991; 13(6): 793.

20. Sukchaya K., Phupong V. Comparative study of positive rate of placental alpha-microglobulin-1 test in pre-term pregnant women with and without uterine contraction. J. Obstet. Gynaecol. 2013; 33(6): 566-8.

21. Rosen S.W. New placental proteins: chemistry, physiology and clinical use. Placenta. 1986; 7(6): 575-94.

22. Петрунин Д.Д., Грязнова И.М., Петрунина Ю.П., Татаринов Ю.С. Иммунологическая идентификация хорионического α1-глобулина плаценты человека и его содержание в амниотической жидкости. Акушерство и гинекология. 1977; 1: 64-5. [Petrunin D.D., Gryaznova I.M., Petrunina Yu.P., Tatarinov Yu.S. Immunological identification of chorionic α1-globulin of the human placenta and its content in the amniotic fluid. Akusherstvo i Ginekologiya/Obstetrics and gynecology. 1977; (1): 64-5. (in Russian)]

23. Lee S.M., Romero R., Park J.W., Kim S.M., Park C.W., Korzeniewski S.J. et al. The clinical significance of a positive Amnisure test (TM) in women with preterm labour and intact membranes. J. Matern. Fetal Neonatal Med. 2012; 25(9): 1690-8.

24. U.S. Food and Drug Administration. Medical Devices. PartoSure Test – P160052. Last Updated: 04/30/2018. Available at: https://www.fda.gov/

25. Nikolova T., Bayev O., Nikolova N., Di Renzo G.C. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J. Perinat. Med. 2014; 42(4): 473-7.

26. Ehsanipoor R.M., Swank M.L., Jwa S.C., Wing D.A., Tarabulsi G., Blakemore K.J. lacental α-microglobulin-1 in vaginal secretions of women with evidence of preterm labor. Am. J. Perinatol. 2016; 33(2): 208-13.

27. Белоцерковцева Л.Д., Коваленко Л.В., Иванников С.Е., Мирзоева Г.Т. Возможности ранней диагностики цервикальной недостаточности для профилактики сверхранних преждевременных родов. Вестник Новгородского государственного университета им. Ярослава Мудрого. 2015; 2: 117-23. [Belotserkovtseva L.D., Kovalenko L.V., Ivannikov S.Ye., Mirzoyeva G.T. Possibilities of early diagnosis of cervical insufficiency for the prevention of early premature births. Vestn. Novg. gos. un-ta. 2015; 2: 117-23. (in Russian)]

28. Ахметгалиев А.Р., Фаткуллин И.Ф. Мунавирова А.А., Фаткуллин Ф.И. Алгоритм идентификации угрозы преждевременных родов. Казанский медицинский журнал. 2017; 1: 132-6. [Akhmetgaliyev A.R., Fatkullin I.F. Munavirova A.A., Fatkullin F.I. Algorithm for identification of the threat of premature birth. Kazanskiy meditsinskiy zhurnal. 2017;1:132-136 (in Russian)]

29. Болотских В.М., Борисова В.Ю. Роль определения биохимических тестов и цервикометрии в диагностике угрожающих преждевременных родов. Акушерство и гинекология. 2015; 2: 94-8. [Bolotskikh V.M., Borisova V.Yu. The role of determining biochemical tests and cervicometry in the diagnosis of threatening premature births. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2015; (2): 94-8. (in Russian)]

30. PartoSure Test. Placental alpha microglobulin-1 immunoassay kit. Instructions for in vitro diagnostic use only. Available at: https://www.accessdata.fda.gov/

Received 08.06.2018

Accepted 22.06.2018